糖尿病黄斑 (DME):剖析病因,预后,诊断方式以及当前和未来的治疗见解
Ahmed Sermed Al Sakini1, Abdulrahman Khaldoon Hamid2, Zainab A Alkhuzaie3
1Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq.
International journal of retina and vitreous
|October 29, 2024
概括
糖尿病黄斑 (DME) 是导致视力丧失的主要原因. 目前的抗VEGF治疗面临挑战,需要研究先进疗法,以更好地控制疾病并减少治疗负担.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 血管生物学 血管生物学
背景情况:
- 糖尿病是一种全球性健康问题,导致血管损伤,特别是影响视网膜.
- 糖尿病黄斑 (DME),糖尿病视网膜病变 (DR) 的并发症,是视力障碍和失明的主要原因.
- 目前的管理策略旨在通过早期干预来预防长期视力丧失.
研究的目的:
- 为DME提供当前治疗药物的全面概述.
- 审查DME管理的新进展和新兴治疗方法.
- 强调需要进一步临床验证创新疗法.
主要方法:
- 进行了彻底的文献搜索.
- 分析了当前使用的DME治疗剂.
- 研究了新兴和未来的治疗方式.
主要成果:
- 抗VEGF药物是DME的第一线治疗方法,包括拉尼比祖马布,布罗卢齐祖马布,贝瓦齐祖马布和阿弗利塞普特.
- 抗VEGF治疗的挑战包括疾病复发,不充分的反应和耐药性.
- 正在研究新的治疗方法,以改善DME的管理.
结论:
- 对DME的先进治疗策略有显著的需求.
- 创新的治疗方法有前途,但需要有力的临床试验证据.
- 进一步的研究是必要的,以支持DME的新治疗方式.
更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
13.2K
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.0K
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
237
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
237
01:27Open Angle Glaucoma: Treatment
397
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
397